On Monday, Qiagen NV (NYSE: QGEN) opened higher 5.36% from the last session, before settling in for the closing price of $38.26. Price fluctuations for QGEN have ranged from $37.63 to $47.92 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 6.09% annually for the last half of the decade. Company’s average yearly earnings per share was noted 1.49% at the time writing. With a float of $214.41 million, this company’s outstanding shares have now reached $216.12 million.
In an organization with 5765 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 49.6%, operating margin of 5.11%, and the pretax margin is 6.12%.
Qiagen NV (QGEN) Insider Updates
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Qiagen NV is 0.79%, while institutional ownership is 74.31%. The most recent insider transaction that took place on Sep 11 ’24, was worth 1,150,000.
Qiagen NV (QGEN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.49% per share during the next fiscal year.
Qiagen NV (NYSE: QGEN) Trading Performance Indicators
Check out the current performance indicators for Qiagen NV (QGEN). In the past quarter, the stock posted a quick ratio of 3.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.40. Likewise, its price to free cash flow for the trailing twelve months is 17.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.37, a number that is poised to hit 0.50 in the next quarter and is forecasted to reach 2.47 in one year’s time.
Technical Analysis of Qiagen NV (QGEN)
Let’s dig in a bit further. During the last 5-days, its volume was 2.02 million. That was better than the volume of 1.26 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 39.87%. Additionally, its Average True Range was 1.02.
During the past 100 days, Qiagen NV’s (QGEN) raw stochastic average was set at 22.97%, which indicates a significant decrease from 65.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.77% in the past 14 days, which was higher than the 26.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $40.38, while its 200-day Moving Average is $44.02. However, in the short run, Qiagen NV’s stock first resistance to watch stands at $41.51. Second resistance stands at $42.72. The third major resistance level sits at $44.13. If the price goes on to break the first support level at $38.89, it is likely to go to the next support level at $37.48. Assuming the price breaks the second support level, the third support level stands at $36.27.
Qiagen NV (NYSE: QGEN) Key Stats
There are currently 222,291K shares outstanding in the company with a market cap of 8.71 billion. Presently, the company’s annual sales total 1,978 M according to its annual income of 83,590 K. Last quarter, the company’s sales amounted to 521,200 K and its income totaled 88,320 K.
